BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 28487158)

  • 1. A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events.
    Faillie JL; Ferrer P; Gouverneur A; Driot D; Berkemeyer S; Vidal X; Martínez-Zapata MJ; Huerta C; Castells X; Rottenkolber M; Schmiedl S; Sabaté M; Ballarín E; Ibáñez L
    J Clin Epidemiol; 2017 Jun; 86():168-175. PubMed ID: 28487158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs.
    Hartling L; Hamm MP; Milne A; Vandermeer B; Santaguida PL; Ansari M; Tsertsvadze A; Hempel S; Shekelle P; Dryden DM
    J Clin Epidemiol; 2013 Sep; 66(9):973-81. PubMed ID: 22981249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool.
    Bilandzic A; Fitzpatrick T; Rosella L; Henry D
    PLoS Med; 2016 Apr; 13(4):e1001987. PubMed ID: 27046153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evidence Project risk of bias tool: assessing study rigor for both randomized and non-randomized intervention studies.
    Kennedy CE; Fonner VA; Armstrong KA; Denison JA; Yeh PT; O'Reilly KR; Sweat MD
    Syst Rev; 2019 Jan; 8(1):3. PubMed ID: 30606262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrater reliability of grading strength of evidence varies with the complexity of the evidence in systematic reviews.
    Berkman ND; Lohr KN; Morgan LC; Kuo TM; Morton SC
    J Clin Epidemiol; 2013 Oct; 66(10):1105-1117.e1. PubMed ID: 23993312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement.
    Hoy D; Brooks P; Woolf A; Blyth F; March L; Bain C; Baker P; Smith E; Buchbinder R
    J Clin Epidemiol; 2012 Sep; 65(9):934-9. PubMed ID: 22742910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of bias in systematic reviews tool showed fair reliability and good construct validity.
    Bühn S; Mathes T; Prengel P; Wegewitz U; Ostermann T; Robens S; Pieper D
    J Clin Epidemiol; 2017 Nov; 91():121-128. PubMed ID: 28694122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.
    Bialy L; Vandermeer B; Lacaze-Masmonteil T; Dryden DM; Hartling L
    Evid Based Child Health; 2014 Dec; 9(4):1052-9. PubMed ID: 25504975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews.
    Vale CL; Tierney JF; Burdett S
    BMJ; 2013 Apr; 346():f1798. PubMed ID: 23610376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research.
    Armijo-Olivo S; Stiles CR; Hagen NA; Biondo PD; Cummings GG
    J Eval Clin Pract; 2012 Feb; 18(1):12-8. PubMed ID: 20698919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the RTI item bank on risk of bias and precision of observational studies.
    Viswanathan M; Berkman ND
    J Clin Epidemiol; 2012 Feb; 65(2):163-78. PubMed ID: 21959223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic reviews of adverse effects: framework for a structured approach.
    Loke YK; Price D; Herxheimer A;
    BMC Med Res Methodol; 2007 Jul; 7():32. PubMed ID: 17615054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the reporting and scientific quality of meta-analyses of randomized controlled trials of treatments for anxiety disorders.
    Bereza BG; Machado M; Einarson TR
    Ann Pharmacother; 2008 Oct; 42(10):1402-9. PubMed ID: 18728102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.
    Downs SH; Black N
    J Epidemiol Community Health; 1998 Jun; 52(6):377-84. PubMed ID: 9764259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PEDro scale had acceptably high convergent validity, construct validity, and interrater reliability in evaluating methodological quality of pharmaceutical trials.
    Yamato TP; Maher C; Koes B; Moseley A
    J Clin Epidemiol; 2017 Jun; 86():176-181. PubMed ID: 28288916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, inter-rater reliability and feasibility of a checklist to assess implementation (Ch-IMP) in systematic reviews: the case of provider-based prevention and treatment programs targeting children and youth.
    Cargo M; Stankov I; Thomas J; Saini M; Rogers P; Mayo-Wilson E; Hannes K
    BMC Med Res Methodol; 2015 Sep; 15():73. PubMed ID: 26346461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment.
    Hammad TA; Neyarapally GA; Pinheiro SP; Iyasu S; Rochester G; Dal Pan G
    Clin Trials; 2013; 10(3):389-97. PubMed ID: 23508987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability.
    Banzi R; Cinquini M; Gonzalez-Lorenzo M; Pecoraro V; Capobussi M; Minozzi S
    J Clin Epidemiol; 2018 Jul; 99():24-32. PubMed ID: 29526556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A checklist to assess the quality of reports on spa therapy and balneotherapy trials was developed using the Delphi consensus method: the SPAC checklist.
    Kamioka H; Kawamura Y; Tsutani K; Maeda M; Hayasaka S; Okuizum H; Okada S; Honda T; Iijima Y
    Complement Ther Med; 2013 Aug; 21(4):324-32. PubMed ID: 23876563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.